Neuroendoscopy Devices Market Size Worth $203.9 Million By 2025

The global neuroendoscopy devices market is expected to reach USD 203.9 million by 2025, according to a new report by Grand View Research, Inc. Demand for neuroendoscopy is increasing due to global rise in number of brain tumor cases and growing adoption of minimally invasive surgical procedures.  

Conventional surgical procedures of brain such as craniotomy is invasive which includes opening of the skull of the patient. This increases the risk of associated conditions such as stroke or hemorrhage, blindness, deafness and in some cases death. Such high risks associated with the conventional surgical procedures of brain are resulting in replacement by adoption of minimally invasive endoscopic procedures.  In addition, increasing cases of pituitary tumors and increasing prevalence of brain cancer is supporting the growth of the market. Few companies engaged in neuroendoscopy manufacturing are B. Braun Medical Inc., Karl Storz, Olympus Corporation, Zeiss International, Stryker, and Medtronic

Click the link below:
https://www.grandviewresearch.com/industry-analysis/neuroendoscopy-market

Further Key Findings from the Study Suggest:

  • Rise in the brain injuries, and neural surgeries coupled with adoption of minimally invasive procedures is driving the growth of the market
  • Intraventricular segment accounted for the largest revenue share in 2016 mainly due to constantly increasing incidences of the intraventricular hemorrhage and bleeding
  • Transcranial surgery segment is expected to grow at the fastest growth rate owing to the factors such as increasing cases of pituitary gland tumors and technological advancements
  • Rigid neuroendoscopes being light weight and small in size are preferred over flexible ones. However, flexible endoscopes segment is expected to grow at the fastest growth rate during the forecast period.
  • Maximum number of neuro-endoscopic procedures are performed in hospitals. Thus, the segment accounted for the largest revenue share in 2016 and is anticipated to remain dominant throughout the forecast period.
  • North America and Europe dominated the market together in 2016. Availability of advanced healthcare infrastructure and high adoption of advanced techniques are some of the prime factors resulting in the highest adoption of neuroendoscopy procedures in these regions.  
  • Key players in the market include B. Braun Medical Inc., Karl Storz, Olympus Corporation, Zeiss International, Stryker, and Medtronic.

Hospital Linen Supply and Management Services Market Worth $9.4 Billion by 2025

The global hospital linen supply and management services market size is anticipated to reach USD 9.4 billion by 2025, according to a new report by Grand View Research, Inc., registering a 3.0% CAGR during the forecast period. Value-added services by key players, increasing outsourcing of hospital linen supplies and services, growing patient base due to rise in various diseases, and increasing geriatric population are key factors that are likely to drive market growth over the forecast period.

Rising prevalence of various diseases such as cardiovascular diseases (CVD), cancer, arthritis, obesity, and diabetes, has expanded the global patient, thereby resulting in growing demand for linen in hospitals. According to WHO, globally, CVDs are the leading cause of death and in 2015, CVD accounted for 31.0% of global deaths. As per the British Heart Foundation, there are approximately 200,000 hospital visits every year due to heart attacks. This, in turn, results in a large patient population base, which propels the growth of the hospital linen supply and management services market. Growing geriatric population prone to various diseases is also a high impact-rendering driver for market growth.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/hospital-linen-supply-and-management-services-market

Further key findings from the report suggest:

  • Bedsheets and pillow covers accounted for the largest share in 2016 owing to increasing number of hospitals and implementation of strict linen hygiene policies
  • Non-woven material is anticipated to witness the highest growth in the market due to advancements in manufacturing technologies
  • The hospitals segment is anticipated to dominate the market in the forecast period due to increasing number of public and private hospitals and rise in patient volume
  • The contractual service provider segment is expected to witness the highest growth due to increasing awareness and demand for hygiene by healthcare professionals and patients
  • The Asia Pacific market is expected to expand at the highest CAGR over the forecast period owing to a massive population base and improving healthcare infrastructure
  • Major players in the market include Unitex Textile Rental Services, Inc.; Emes Textiles Pvt. Ltd.; Angelica Corporation; E-town Laundry Company; Healthcare Services Group, Inc.; ImageFIRST Healthcare Laundry Specialists, Inc.; Tetsudo Linen Service; Celtic Linen; Swisslog Holding AG; and AmeriPride Services Inc.

Epigenetics Market Size Worth $22.05 Billion By 2025

The global epigenetics market size is expected to reach USD 22.05 billion by 2025, according to a new study by Grand View Research, Inc., progressing at a CAGR of 19.7% during the forecast period. The growing prevalence of cancer and other diseases worldwide with an epigenetic modification base is expected to drive the market during the forecast period.

Diagnostic companies are coming up with new products such as antibodies specific for the detection of modifications and new upgraded kits for easy and efficient detection of biomarkers. This is estimated to attract pharmaceutical companies to collaborate for the development of therapeutic drugs, which will work in favor of the market.

The presence of pipeline drugs and their expected commercialization is anticipated to boost the growth of the market. For instance, Ramucirumab (Cyramza) by Eli Lilly and Company was approved by the FDA for use in combination with Folfiri for the treatment of patients with metastatic colorectal cancer.

Technology advancements in the epigenetics industry are majorly focusing on the detection of methylation markers related to cancer development. For instance, Epi proLung BL Reflex Assay by Epigenomics helps in the diagnosis of lung cancer by determining methylation of SHOX2 biomarker gene.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/epigenetics-market

Further key findings from the study suggest:

  • On the basis of product, reagents held the largest share in the market in 2017. They are projected to amount to approximately USD 7.06 billion by 2025 owing to increasing R&D activities in the field of epigenetics
  • The kits segment is expected to post a CAGR of over 20.0% due to the need for rapid and accurate detection techniques
  • DNA methylation, on the basis of technology, held the leading revenue share in the market in 2017, accounting for just over 47.0%. The rapid adoption of advanced techniques such as methylation-sensitive PCR (MSP) to improve diagnostics efficiency is poised to bolster the growth of the segment
  • North America commanded the leading position in the global arena with a share of 40.0% in 2017. The growth of the regional market can be attributed to the increasing prevalence of cancer and growing collaborations between large pharmaceutical firms for the development of improved therapeutics
  • Asia Pacific is estimated to register a noteworthy CAGR of 22.1% during the forecast period owing to the presence of a large target population coupled with high unmet clinical needs
  • Some of the major players of epigenetics market are Illumina; Abcam; Diagenode; Thermo Fisher Scientific; Merck; Zymo research; Qiagen; CellCentric Ltd; Chroma Therapeutics Ltd; Eisai Co. Ltd; Novartis International AG; Oncolys Biopharma Inc.; Syndax Pharmaceuticals, Inc.; Valirx Plc; and Sigma-Aldrich Corporation
  • Extensive R&D initiatives for the development of novel drugs and the presence of strong product pipeline are expected to further boost market growth over the forecast period.

Smart Homes Market Size To Reach USD 47.61 Billion By 2020

The global smart homes market is expected to reach USD 47.61 billion by 2020, according to a new study by Grand View Research, Inc. Emphasis on reduced carbon emission and energy conservation are expected to be the key driving forces for the market over the forecast period. Favorable regulatory initiatives for implementing smart homes owing to their energy efficiency characteristics are further expected to positively impact the global market over the next six years.

Increased aging population, which comprises a majority of end-users of this technology, is also expected to boost market growth. Introduction of smart grids, increased personal income in developing economies, assistance of power line communication, and growth of consumer electronics industry are factors expected to favorably impact market growth. Need for standardization, skilled labor and high initial cost due to the incorporation of advanced technologies such as IP and Bluetooth may pose a challenge to industry growth.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/Smart-Homes-Industry

Further key findings from the study suggest:

  • Security applications dominated the global market and accounted for over 20% of the overall market share in 2013. This is primarily owing to techniques such as security cameras, window sensor alarms and burglar alarms which notify users of a possible security breach. Energy management segment is expected to witness the fastest growth on account of growing awareness regarding energy efficiency coupled with the support of regulatory bodies for development of a smart grid and installation of smart electricity, water, and gas meters.
  • North America is expected to remain the market leader over the forecast period, and accounted for 41.3% of the global market revenue in 2013. The market in Europe is expected to grow at a CAGR of 21.3% from 2014 to 2020, owing to growing adoption of smart home systems.
  • Key industry participants include ABB Ltd., Siemens AG, Crestron Electronics, Inc., Honeywell, Emerson Electric Co., Schneider Electric S.A., Legrand S.A., Lutron Electronics, Inc., Ingersoll-Rand PLC, Tyco International Ltd., AMX and Control4 Corporation.

Electric Vehicle Market Worth $1,212.1 Billion By 2027

The global electric vehicle market demand is expected to reach $1,212.1 billion by 2027, expanding at a CAGR of 38.1% over the forecast period, according to a study conducted by Grand View Research, Inc. The market is driven by initiatives taken by governments of various countries to promote manufacturing of Electric Vehicles (EVs). For instance, the Electric Vehicles Initiative (EVI), a multi-government forum, aims at increasing the adoption of EVs globally. As of now, there are thirteen countries participating in this forum, namely Canada, Chile, U.K., Germany, Sweden, Netherlands, Norway, Finland, France, China, Japan, India, and New Zealand. Several campaigns and programs have been launched under this forum such as the EV30@30 in 2017, which sets a target for 11 countries to have at least 30.0% sales of new EVs by 2030.

Rising investments in the EVs by numerous manufacturers is one of the key market drivers over the forecast period. For instance, in January 2020, General Motors announced its plan to invest USD 2.2 Billion in its Detroit plant to manufacture electric trucks and SUVs. The company plans to introduce over 20 EVs by 2023. Furthermore, in 2018, the demand for global electric cars surpassed 5 million units, more than 2 million units from 2017. China is considered as one of the major markets of electric cars along with Europe and U.S. However, lack of infrastructure is anticipated to hinder electric vehicle market growth over the forecast period.

Growing awareness regarding reduction of air pollution is propelling the demand for EVs during the forecast timeframe. EVs produce less carbon emissions as compared to conventional gasoline cars. It is estimated that EVs emit an average of 4,450 pounds of CO2 equivalents every year, which is almost half of the carbon emissions generated by conventional gasoline cars annually. Thus, EVs help in reducing air pollution and improve the air quality, thereby improving public health. This has led various government agencies promote the usage of electric vehicles. For instance, the U.S. Department of Transportation, Great Plains Institute, and Pollution Control Agency are working in tandem to accelerate the adoption of EVs in Minnesota, U.S.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/electric-vehicles-ev-market

Further key findings from the study suggest:

  • The Plug-in Hybrid Electric Vehicles (PHEV) segment is projected to witness the fastest CAGR of over 45.0% in terms of revenue during the forecast period owing to the advantages of two power sources, electricity and fuel
  • The Battery Electric Vehicles (BEV) segment is expected to hold the largest market share of over 60.0% in terms of revenue in 2019. This share is attributed to the initiatives taken by government of countries such as Germany, Sweden, China, and India to promote the usage of EVs
  • Asia Pacific held a market share of over 60.0% in terms of revenue in 2019. However, Latin America is anticipated to witness the fastest CAGR of over 75.0% in terms of revenue during the forecast period. This growth is attributed to the growing environmental awareness among the citizens of Brazil
  • The electric vehicle market is consolidated and characterized by high competition with the presence of major global players such as BYD Company Ltd.; Daimler AG; Ford Motor Company; General Motors Company; Groupe Renault; Mitsubishi Motors Corporation; Nissan Motor Company; Tesla, Inc.; Toyota Motor Corporation; and Volkswagen Group. These companies are engaged in collaborations, mergers, and acquisitions to enhance their market presence and to expand their product portfolio

Automotive Aftermarket Size Worth $513.8 Billion By 2027

The global automotive aftermarket size is expected to reach USD 513.8 billion by 2027, registering a CAGR of 4.0% over the forecast period, according to a new report by Grand View Research, Inc. Digitalization of automotive repair and component sales, along with advanced technology incorporations in the automobile aftermarket component manufacturing, is expected to boost the market growth. Increasing adoption of semi-autonomous, electric vehicles, and hybrid and autonomous cars is further expected to bolster the market growth.

Increasing disposable income and improved lifestyle in developing countries such as India and Brazil are leading to increased vehicle penetration, which is expected to drive the market in the region. Growth in the automotive manufacturing sector across various regions, along with stringent emissions norms, are expected to drive the aftermarket component sales over the forecast period. Third party services and technological advancements offer new and profitable revenue streams to leverage these opportunities. In addition, the industry requires investment in product development, supply chain, organizational design, and pricing model to create significant surge in the demand.

Manufacturers in developing countries are adopting various strategies, including mergers, acquisitions, and partnerships to gain a strong foothold in the market. Asia Pacific is expected to be the fastest growing regional market owing to improving living standards and high automobile production. With increasing penetration and acceptance of gas and hybrid electric cars, specialized repair centers, dedicated toward repairing of particular vehicles, are expected to increase.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/aftermarket-automotive-parts-market

Further key findings from the report suggest:

  • The aftermarket is estimated to grow significantly over the forecast period owing to increasing number of lightweight vehicles along with increasing age of the light vehicle fleet
  • Innovative business models and solutions provided by the manufacturers and growing investments in the same, are expected to create sustainable growth opportunities for the market
  • North America has a higher technology adoption rate, which is anticipated to result in faster and higher adoption of hybrid electric automobiles in the region as compared to other geographies
  • The automotive aftermarket is anticipated to witness a phase change owing to the growing proportion of specialized automotive collision repair centers that are dedicated toward serving specific vehicles such as alternate fuel powered vehicles
  • Key industry participants include Magneti Marelli S.p.A., Continental AG, 3M Company, Federal-Mogul Corporation, Delphi Automotive PLC, Robert Bosch GmbH, and Denso Corporation.

Healthcare Cloud Computing Market Size Worth $27.8 Billion By 2026

The global healthcare cloud computing market size is expected to reach USD 27.8 billion by 2026, according to a new report by Grand View Research, exhibiting a CAGR of 11.8% over the forecast period. The associated benefits of data analytics and increase in demand for flexible & scalable data storage by healthcare professionals is expected to drive the demand for these services over the forecast period.

Healthcare organizations are digitalizing their IT infrastructure and deploying cloud servers to improve features of systems. These solutions help organizations in reducing infrastructure cost & interoperability issues and aid in complying with regulatory standards. Hence, rising demand from health professionals to curb IT infrastructure costs and limit space usage are anticipated to boost market growth over the forecast period.

Increase in government initiatives undertaken to develop and deploy IT systems in this industry is one of the key drivers of this market. Moreover, increase in partnerships between private & public players and presence of a large number of players offering customized solutions are some of the factors anticipated to drive demand in the coming years.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/healthcare-cloud-computing-market

Further key findings from the report suggest:

  • Non-clinical information systems such as revenue cycle management, health information exchange, financial management, etc., accounted for the largest revenue share in application segment in 2018
  • Financial management segment held 23.0% share of the non-clinical segment in 2018 while billing and accounts management is expected to grow at the considerable CAGR during the forecast period
  • Private deployment model dominated the overall market owing to its benefits and ease of usage
  • Software as a Service (SaaS) model accounted for the largest revenue share as of 2018 as it is widely accepted. This model enables access to applications on a cloud from various devices
  • Pay-as-you-go pricing model is anticipated to gain popularity in the coming years, as the consumer only pays for services being used
  • North America dominated the market with a share of over 55.0% in 2018. This can be attributed to an increase in demand from payers as well as providers
  • Some key players of this healthcare cloud computing market include Athenahealth, Cerner Corporation, CareCloud Corporation, Carestream Corporation, Epic Systems Corporation, Dell Inc., and Sectra AB
  • Companies are forming various strategic alliances with clinical research organizations and medical devices companies to further expand their profit margins in the healthcare IT sector. These type of strategic collaborations are expected to aid market growth in the coming years.

Healthcare Business Intelligence Market Worth $10.64 Billion By 2025

The global healthcare business intelligence market size is expected to reach USD 10.64 billion by 2025, registering a CAGR of 12.8% during the forecast period, according to a new report by Grand View Research, Inc. Increase in adoption of data-driven decision making, emergence of cloud based business intelligence (BI) solutions for healthcare industry, increased focus to reduce spending, and emergence of mobile-based healthcare BI solutions are the key factors contributing to the growth. Growing requirement of business intelligence tools to reduce costs for operational performance, claims, and clinical analysis is another major factor positively impacting the market.

Factors, such as the constantly increasing volume of digital information and data sources, complexity of data generated in healthcare organizations, coupled with growing need for the advanced business intelligence solutions to support decision-making are boosting the demand for business intelligence solutions and services. The massive amounts of unstructured and structured data generated by medical organizations and institutions is critical to manage, thus there is huge requirement for advanced healthcare BI software by hospitals and other healthcare organizations.

In order to gain insights about patient care and satisfaction, clinical operations, labor distribution, physician practices, and administration and management; hospitals and other healthcare facilities require data visualization and predictive modeling tools, which in turn is increasing demand for healthcare business intelligence software among these end users.

Increasing adoption of cloud-based healthcare BI software solutions coupled with high dependency of healthcare on digital technology to operate functions of a complex healthcare system is further boosting the adoption of BI software over the past years. For instance, KenSci Clinical Analytics, a platform designed by Microsoft to predict clinical and operational risk involved in a healthcare facility to improve health outcomes and reduce operational costs.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/healthcare-business-intelligence-market

Further key findings from the study suggest:

  • Software emerged as the largest product segment with a revenue share of 68.4% in 2018
  • Cloud-based mode of delivery accounted for the largest revenue share in 2018 and is expected to register the fastest CAGR over the forecast period
  • Healthcare payers emerged as the leading end use segment, however healthcare providers end use segment is expected to grow at a significant CAGR over the forecast period
  • North America accounted for the largest share of the healthcare business intelligence market due to increased implementation of healthcare BI solutions and services by the providers to offer enhanced patient care and reduced healthcare expenses
  • Market players, such Oracle Corporation; SAP; Microsoft; Salesforce; Tableau Software; TIBCO Software Inc.; Sisense Inc.; and Looker Data Sciences, Inc. are focused on increasing collaboration with powerful analytics platform providers to gain competitive edge in the market

Drug Eluting Stent Market Size To Reach $9.2 Billion By 2024

The global drug eluting stent market is anticipated to reach USD 9.2 billion by 2024, according to a new report by Grand View Research, Inc. The increasing geriatric population and the high prevalence of artery diseases are the major factors driving the market growth. Sedentary lifestyles, unhealthy dietary habits, and lack of exercise are some of the factors resulting in the increased prevalence of atherosclerosis. As a result, the demand for Drug Eluting Stents (DES) is escalating as atherosclerosis is widely treated using DES. In addition, a constant decline in the price coupled with the reimbursement coverage is spurring the adoption of DES in the treatment of arterial diseases.

Risks, such as thrombosis and disruption of regrowth of endothelial tissues associated with DES, are challenging the market growth. In addition, stringent regulatory approval guidelines are impeding the market growth by restricting the entry of advanced DES, such as bioabsorbable products, in the developed countries.

Presently, the DES market is highly fragmented with the presence of many players competing with each other. The key players in the market are implementing mergers and acquisitions strategies to strengthen their position in the market by the expansion of market share and customer base.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/drug-eluting-stent-market

Further key findings from the study suggest:

  • The polymer-based coating stent segment was dominating the global market and is estimated to remain dominant throughout the forecast period. The increasing adoption of biodegradable stents is mainly driving the growth of the polymer-based coating stents segment.
  • The biodegradable polymer-based drug eluting stents are anticipated to have a high demand during the forecast period due to a minimally invasive technique and lesser risk of late stent thrombosis.
  • The demand for polymer-free drug eluting stents is going to increase considerably with new products entering the market, especially in emerging countries such as Brazil, Mexico, and South Africa.
  • China, India, Brazil, and South Africa are anticipated to register a significant growth in the near future owing to the rising patient awareness related to DES, presence of the largest pool of geriatric population prone to arterial diseases, and the surging prevalence of chronic diseases such as diabetes and cardiac disorders
  • Less stringent regulatory approval procedures in Asia Pacific are offering the easy entry of the new products into the market.
  • Some key players operating in the market include Boston Scientific Corporation, Medtronic, Inc., Abbott Laboratories, Biosensors International Group, Lepu Medical Technology, Biotronik, Stentys, and Terumo Medical Corporation.
  • North America dominated the global market with a share of 40% in 2015. Technological advancements, such as the introduction of biodegradable stents primarily, led to the highest revenue generation in the region.
  • In addition, the reimbursement coverage, the presence of a large target patient population, and a well-defined regulatory framework are a few factors that are positively affecting the market.

Advanced Wound Care Market Size Worth $9.3 Billion By 2027

The global advanced wound care market size is expected to reach USD 9.3 billion by 2027, expanding at a CAGR of 5.2% over the forecast period, according to a new report by Grand View Research, Inc. Rising surgical procedures and increasing number of ambulatory surgical centers (ASCs) are some of the key factors driving the market for advanced wound care.

Rising number of road accidents is one of the major factors increasing the demand for advanced wound care products. Moist wound care such as foam, hydrocolloid, film, and collagen dressings are used for the injuries caused by road crash. These advanced wound dressings keep the injury hydrated and allow rapid healing. Moreover, patients who have suffered from severe road crash injuries, such as 2nd and 3rd degree burns, are treated using skin-substitutes and biomaterials.

According to the Association for Safe International Road Travel (ASIRT), approximately 20-50 million people suffer from injuries and disability from road crash globally. It also reported that road accidents are the ninth leading cause of death globally.

In addition, the WHO reported that road accidents cost most of the countries around 3.00% of their gross domestic product (GDP). Factors responsible for road accidents include speeding, alcohol and psychoactive substance influence, unsafe road infrastructure and vehicles, non-use of helmets and seat belts, distracted driving, inadequate post-crash care, and inadequate law enforcement. According to the WHO, 93% of the world’s road fatalities occur in low and middle income countries due to the aforementioned factors.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/advanced-wound-care-market

Further key findings from the study suggest:

  • By product, the moist segment held the largest market share in 2019 as it is used in providing first-aid to the patients
  • Based on application, the chronic segment is anticipated to witness the fastest growth over the forecast period owing to rising cases of diabetes among all age groups
  • On the basis of end use, home healthcare is expected to witness the fastest growth over the forecast period due to increasing demand for reduced hospital stay and growing geriatric population
  • Asia Pacific is expected to witness the fastest growth over the forecast period owing to rising number of surgical procedures and increasing cases of sports injuries
  • Key players operating in the advanced wound care market include Smith & Nephew PLC; Molnlycke Health Care AB; Acelity (KCI Licensing, Inc.); ConvaTec Group PLC; Baxter; Coloplast Corp.; Medtronic; 3M; Derma Sciences Inc. (Integra Lifesciences); and Medline Industries, Inc.